← All companies

CALC

CalciMedica, Inc.

CALC Nasdaq Pharmaceutical Preparations EDGAR ↗

$0.75

-0.25 -24.70%

Key statistics

from XBRL data in SEC filings

Market cap

$11.9M

Revenue (TTM)

—

Net income (TTM)

-$19.5M

EPS (TTM)

$-1.31

P/E ratio

—

Dividend yield

—

Free cash flow

-$21.2M

Cash

$8.16M

Total assets

$8.61M

Gross margin

—

52-week range

$0.46 – $7.20

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Director or officer change Jul 7, 2026 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure; Other events Jun 24, 2026 8-K Entered a material agreement; Unregistered sale of equity Jun 24, 2026 10-Q Quarter ended 2026-03-31 May 12, 2026 8-K Results of operations (earnings release) May 12, 2026 10-K/A Fiscal year ended 2025-12-31 Apr 30, 2026 8-K Delisting notice or listing-rule failure Mar 18, 2026 10-K Fiscal year ended 2025-12-31 Mar 3, 2026 8-K Results of operations (earnings release) Mar 3, 2026 8-K Other events Jan 28, 2026 8-K Regulation FD disclosure; Other events Jan 28, 2026 10-Q Quarter ended 2025-09-30 Nov 12, 2025 8-K Results of operations (earnings release) Nov 12, 2025 8-K Other events Nov 6, 2025 10-Q Quarter ended 2025-06-30 Aug 12, 2025 8-K Results of operations (earnings release) Aug 12, 2025 8-K Director or officer change; Shareholder vote results Jun 27, 2025 8-K Changed accountants Jun 6, 2025 10-Q Quarter ended 2025-03-31 May 14, 2025 8-K Results of operations (earnings release) May 14, 2025 10-K Fiscal year ended 2024-12-31 Mar 27, 2025 8-K Results of operations (earnings release) Mar 27, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Other events Mar 5, 2025 8-K Regulation FD disclosure; Other events Mar 4, 2025 8-K Director or officer change Jan 14, 2025 8-K Other events Dec 20, 2024 10-Q Quarter ended 2024-09-30 Nov 13, 2024 8-K Results of operations (earnings release) Nov 13, 2024 8-K Director or officer change Nov 8, 2024 8-K Entered a material agreement; Other events Oct 31, 2024 8-K Results of operations (earnings release); Other events Oct 30, 2024 8-K Regulation FD disclosure; Other events Oct 30, 2024 8-K Director or officer change; Shareholder vote results Aug 27, 2024 10-Q Quarter ended 2024-06-30 Aug 12, 2024 8-K Results of operations (earnings release) Aug 12, 2024 8-K Regulation FD disclosure; Other events Jun 27, 2024 10-Q Quarter ended 2024-03-31 May 13, 2024 8-K Results of operations (earnings release) May 13, 2024 10-K/A Fiscal year ended 2023-12-31 Apr 29, 2024 8-K Changed accountants Apr 10, 2024